Scientific article
Meta-analysis
English

Effect of ivabradine on major adverse cardiovascular events and mortality in critically ill patients: a systematic review and meta-analyses of randomised controlled trials with trial sequential analyses

Published inBritish Journal of Anaesthesia, vol. 124, no. 6, p. 726-738
Publication date2020
Abstract

Ivabradine lowers heart rate (HR) without affecting contractility or vascular tone. It is licensed for HR control in chronic heart diseases. We performed a systematic review and meta-analyses to examine whether ivabradine could decrease major adverse cardiovascular events (MACE) and mortality in critically ill patients.

Keywords
  • Cardiovascular Agents/therapeutic use
  • Critical Illness
  • Heart Diseases/drug therapy/mortality/physiopathology
  • Humans
  • Ivabradine/therapeutic use
  • Treatment Outcome
Citation (ISO format)
CHEN, Aileen et al. Effect of ivabradine on major adverse cardiovascular events and mortality in critically ill patients: a systematic review and meta-analyses of randomised controlled trials with trial sequential analyses. In: British Journal of Anaesthesia, 2020, vol. 124, n° 6, p. 726–738. doi: 10.1016/j.bja.2020.01.027
Main files (1)
Article (Published version)
accessLevelRestricted
Secondary files (1)
Supplemental data
accessLevelRestricted
Identifiers
Journal ISSN0007-0912
301views
5downloads

Technical informations

Creation12/08/2020 17:04:00
First validation12/08/2020 17:04:00
Update27/06/2024 08:59:49
Status update15/03/2023 22:46:56
Last indexation30/09/2025 05:34:54
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack